Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Philippe Moreau. (2014) The emerging role of carfilzomib combination therapy in the management of multiple myeloma. Expert Review of Hematology 7:2, pages 265-290.
Read now
Read now
Rainer Metcalf, Latanya M Scott, Kenyon G Daniel & Q Ping Dou. (2014) Proteasome inhibitor patents (2010 – present). Expert Opinion on Therapeutic Patents 24:4, pages 369-382.
Read now
Read now
Yuri Pevzner, Rainer Metcalf, Melanie Kantor, Desiree Sagaro & Kenyon Daniel. (2013) Recent advances in proteasome inhibitor discovery. Expert Opinion on Drug Discovery 8:5, pages 537-568.
Read now
Read now
Articles from other publishers (6)
Danai Dima, Dongxu Jiang, Divya Jyoti Singh, Metis Hasipek, Haikoo S. Shah, Fauzia Ullah, Jack Khouri, Jaroslaw P. Maciejewski & Babal K. Jha. (2022) Multiple Myeloma Therapy: Emerging Trends and Challenges. Cancers 14:17, pages 4082.
Crossref
Crossref
Bruna Domingues Vieira, Henrique Niero, Rafael de Felício, Luiz Fernando Giolo Alves, Cristina Freitas Bazzano, Renata Sigrist, Luciana Costa Furtado, Gabriela Felix Persinoti, Leticia Veras Costa-Lotufo & Daniela Barretto Barbosa Trivella. (2022) Production of Epoxyketone Peptide-Based Proteasome Inhibitors by Streptomyces sp. BRA-346: Regulation and Biosynthesis. Frontiers in Microbiology 13.
Crossref
Crossref
Bo-Tao Xin, Eva M. Huber, Gerjan de Bruin, Wolfgang Heinemeyer, Elmer Maurits, Christofer Espinal, Yimeng Du, Marissa Janssens, Emily S. Weyburne, Alexei F. Kisselev, Bogdan I. Florea, Christoph Driessen, Gijsbert A. van der Marel, Michael Groll & Herman S. Overkleeft. (2019) Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits. Journal of Medicinal Chemistry 62:3, pages 1626-1642.
Crossref
Crossref
Ya-Min Cheng, Po-Lin Lin, De-Wei Wu, Lee Wang, Chi-Chou Huang & Huei Lee. (2018) PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2. Oncotarget 9:41, pages 26342-26352.
Crossref
Crossref
Minjie Gao, Gege Chen, Houcai Wang, Bingqian Xie, Liangning Hu, Yuanyuan Kong, Guang Yang, Yi Tao, Ying Han, Xiaosong Wu, Yiwen Zhang, Bojie Dai & Jumei Shi. (2016) Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma. Oncotarget 7:20, pages 29102-29115.
Crossref
Crossref
Lu Gao, Minjie Gao, Guang Yang, Yi Tao, Yuanyuan Kong, Ruixue Yang, Xiuqin Meng, Gongwen Ai, Rong Wei, Huiqun Wu, Xiaosong Wu & Jumei Shi. (2015) Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2. BioMed Research International 2015, pages 1-9.
Crossref
Crossref